Inclusion of patients and informed consent Our observational cohort is designed for continuous inclusion and longitudinal follow-up of newly diagnosed patients with RCC in the Netherlands (localized, locally advanced or with synchronous metastases) and also for patients with metachronous metastases. All Dutch inhabitants from the age of 18 years with histologically proven or high clinical suspicion of (m)RCC are eligible for inclusion.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile